Presentation is loading. Please wait.

Presentation is loading. Please wait.

Summary of the OA biomarkers workshop 2009 – biochemical biomarkers: biology, validation, and clinical studies  V.B. Kraus, M. Nevitt, L.J. Sandell  Osteoarthritis.

Similar presentations


Presentation on theme: "Summary of the OA biomarkers workshop 2009 – biochemical biomarkers: biology, validation, and clinical studies  V.B. Kraus, M. Nevitt, L.J. Sandell  Osteoarthritis."— Presentation transcript:

1 Summary of the OA biomarkers workshop 2009 – biochemical biomarkers: biology, validation, and clinical studies  V.B. Kraus, M. Nevitt, L.J. Sandell  Osteoarthritis and Cartilage  Volume 18, Issue 6, Pages (June 2010) DOI: /j.joca Copyright © 2010 Osteoarthritis Research Society International Terms and Conditions

2 Fig. 1 OA is typically a slow, insidious and debilitating process that, like other prominent chronic diseases, is likely more amenable to remission early in the disease process. With a renewed focus on acute joint injury and the prevalence of severe consequences, the concept that “Joint infarction like myocardial infarction requires acute intervention” is conveyed to foster debate, discussion, and research, in order to discover new treatment paradigms to make a lasting difference in outcomes. Osteoarthritis and Cartilage  , DOI: ( /j.joca ) Copyright © 2010 Osteoarthritis Research Society International Terms and Conditions


Download ppt "Summary of the OA biomarkers workshop 2009 – biochemical biomarkers: biology, validation, and clinical studies  V.B. Kraus, M. Nevitt, L.J. Sandell  Osteoarthritis."

Similar presentations


Ads by Google